OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Evidio Domingo‐Musibay, Paari Murugan, Alessio Giubellino, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 61
Evidio Domingo‐Musibay, Paari Murugan, Alessio Giubellino, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 61
Showing 1-25 of 61 citing articles:
Sebaceous carcinoma: evidence-based clinical practice guidelines
Joshua L. Owen, Nour Kibbi, Brandon Worley, et al.
The Lancet Oncology (2019) Vol. 20, Iss. 12, pp. e699-e714
Closed Access | Times Cited: 171
Joshua L. Owen, Nour Kibbi, Brandon Worley, et al.
The Lancet Oncology (2019) Vol. 20, Iss. 12, pp. e699-e714
Closed Access | Times Cited: 171
LRP1Bmutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
Landon C. Brown, Matthew D. Tucker, Ramy Sedhom, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e001792-e001792
Open Access | Times Cited: 86
Landon C. Brown, Matthew D. Tucker, Ramy Sedhom, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e001792-e001792
Open Access | Times Cited: 86
Immunotherapy for Non-melanoma Skin Cancer
Sophia Z. Shalhout, Kevin S. Emerick, Howard L. Kaufman, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 82
Sophia Z. Shalhout, Kevin S. Emerick, Howard L. Kaufman, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 82
Immune checkpoint inhibitors to treat cutaneous malignancies
Dulce M. Barrios, H. Mytrang, Gregory S. Phillips, et al.
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 5, pp. 1239-1253
Open Access | Times Cited: 78
Dulce M. Barrios, H. Mytrang, Gregory S. Phillips, et al.
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 5, pp. 1239-1253
Open Access | Times Cited: 78
Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation
Chang Liu, Miao Wang, Changli Xu, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-18
Open Access | Times Cited: 44
Chang Liu, Miao Wang, Changli Xu, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-18
Open Access | Times Cited: 44
Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management
Federica Dini, Pietro Susini, Giuseppe Nisi, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 6, pp. 726-736
Closed Access | Times Cited: 6
Federica Dini, Pietro Susini, Giuseppe Nisi, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 6, pp. 726-736
Closed Access | Times Cited: 6
S1‐Guideline Sebaceous Carcinoma
Jochen Utikal, Pia Nagel, Verena Müller, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 5, pp. 730-747
Open Access | Times Cited: 6
Jochen Utikal, Pia Nagel, Verena Müller, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 5, pp. 730-747
Open Access | Times Cited: 6
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
Ann W. Silk, Christopher A. Barker, Shailender Bhatia, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004434-e004434
Open Access | Times Cited: 28
Ann W. Silk, Christopher A. Barker, Shailender Bhatia, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004434-e004434
Open Access | Times Cited: 28
Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review
Franchesca Choi, Christina N. Kraus, Ashley Elsensohn, et al.
Journal of the American Academy of Dermatology (2019) Vol. 82, Iss. 2, pp. 440-459
Closed Access | Times Cited: 41
Franchesca Choi, Christina N. Kraus, Ashley Elsensohn, et al.
Journal of the American Academy of Dermatology (2019) Vol. 82, Iss. 2, pp. 440-459
Closed Access | Times Cited: 41
Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer
Keiji Tanese, Yoshio Nakamura, Ikuko Hirai, et al.
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 40
Keiji Tanese, Yoshio Nakamura, Ikuko Hirai, et al.
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 40
Orbital exenteration: an updated review with perspectives
Arnaud Martel, Stéphanie Baillif, Sacha Nahon‐Estève, et al.
Survey of Ophthalmology (2021) Vol. 66, Iss. 5, pp. 856-876
Closed Access | Times Cited: 28
Arnaud Martel, Stéphanie Baillif, Sacha Nahon‐Estève, et al.
Survey of Ophthalmology (2021) Vol. 66, Iss. 5, pp. 856-876
Closed Access | Times Cited: 28
Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes
Sophia Z. Shalhout, Howard L. Kaufman, Kevin S. Emerick, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 11, pp. 2211-2220
Open Access | Times Cited: 21
Sophia Z. Shalhout, Howard L. Kaufman, Kevin S. Emerick, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 11, pp. 2211-2220
Open Access | Times Cited: 21
Case report: Pilomatrix carcinoma with PDL1 expression and CDKN2A aberrant
Ayinuer Abula, Sheng-Qiang Ma, Sisi Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Ayinuer Abula, Sheng-Qiang Ma, Sisi Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Sebaceous carcinoma of the intraoral origin: a literature review
Yousef Katib
ONCOLOGIE (2025)
Closed Access
Yousef Katib
ONCOLOGIE (2025)
Closed Access
Genetic Drivers in Sebaceous Neoplasms: A Review of Germline and Somatic Mutations and Their Role in Treatment and Management Strategies
Christina Fujii, Akira Mochizuki, Sandra Dreike, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 659-659
Open Access
Christina Fujii, Akira Mochizuki, Sandra Dreike, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 659-659
Open Access
Timing of nodal metastasis in patients with eyelid sebaceous carcinoma and implications for surveillance and survival
Tracy Lu, Casey Anthony, Xinyang Jiang, et al.
British Journal of Ophthalmology (2025), pp. bjo-326923
Closed Access
Tracy Lu, Casey Anthony, Xinyang Jiang, et al.
British Journal of Ophthalmology (2025), pp. bjo-326923
Closed Access
Mapping the potential for anti-PD-1 therapy in advanced rare skin carcinomas
Clio Dessinioti, Alexander J. Stratigos
European Journal of Cancer (2025), pp. 115403-115403
Closed Access
Clio Dessinioti, Alexander J. Stratigos
European Journal of Cancer (2025), pp. 115403-115403
Closed Access
Therapie bei malignen Lidtumoren
Antonio Bergua
Springer Reference Medizin (2025), pp. 1761-1777
Closed Access
Antonio Bergua
Springer Reference Medizin (2025), pp. 1761-1777
Closed Access
Sebaceous carcinoma: controversies and their evidence for clinical practice
Nour Kibbi, Brandon Worley, Joshua L. Owen, et al.
Archives of Dermatological Research (2019) Vol. 312, Iss. 1, pp. 25-31
Closed Access | Times Cited: 27
Nour Kibbi, Brandon Worley, Joshua L. Owen, et al.
Archives of Dermatological Research (2019) Vol. 312, Iss. 1, pp. 25-31
Closed Access | Times Cited: 27
Sebaceous carcinoma: an updated review of pathogenesis, diagnosis, and treatment options
Caitlin Dowell‐Esquivel, R K Lee, Robert C. DiCaprio, et al.
Archives of Dermatological Research (2023) Vol. 316, Iss. 1
Closed Access | Times Cited: 8
Caitlin Dowell‐Esquivel, R K Lee, Robert C. DiCaprio, et al.
Archives of Dermatological Research (2023) Vol. 316, Iss. 1
Closed Access | Times Cited: 8
Review of recent advances in managing periocular skin malignancies
Daniel C. Trotier, Leslie Huang, Suzanne W. van Landingham, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Daniel C. Trotier, Leslie Huang, Suzanne W. van Landingham, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Cutaneous sebaceous carcinoma
Albert Wu, Saul Rajak, Shyamala C. Huilgol, et al.
Australasian Journal of Dermatology (2020) Vol. 61, Iss. 3
Closed Access | Times Cited: 22
Albert Wu, Saul Rajak, Shyamala C. Huilgol, et al.
Australasian Journal of Dermatology (2020) Vol. 61, Iss. 3
Closed Access | Times Cited: 22
Diagnosis and treatment of malignant eyelid tumors
S. Gniesmer, Svenja Rebecca Sonntag, Christian Schiemenz, et al.
Deleted Journal (2023) Vol. 121, Iss. S1, pp. 33-39
Closed Access | Times Cited: 7
S. Gniesmer, Svenja Rebecca Sonntag, Christian Schiemenz, et al.
Deleted Journal (2023) Vol. 121, Iss. S1, pp. 33-39
Closed Access | Times Cited: 7
Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective
Marcin Kleibert, Iga Płachta, Anna M. Czarnecka, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 998-998
Open Access | Times Cited: 12
Marcin Kleibert, Iga Płachta, Anna M. Czarnecka, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 998-998
Open Access | Times Cited: 12
Outcome after treatment for sebaceous carcinoma: A multicenter study
Eva A. Huis in ’t Veld, Ronald O. B. de Keizer, Nicoline F. Post, et al.
Journal of Surgical Oncology (2022) Vol. 125, Iss. 4, pp. 730-735
Open Access | Times Cited: 12
Eva A. Huis in ’t Veld, Ronald O. B. de Keizer, Nicoline F. Post, et al.
Journal of Surgical Oncology (2022) Vol. 125, Iss. 4, pp. 730-735
Open Access | Times Cited: 12
